Table 4.
List of the molecular moiety and benefits of different nanocarriers.
S. No. | Nanocarriers | Molecular Moiety | Benefits | References | |
---|---|---|---|---|---|
Organic Nanocarriers | |||||
1. | Polymeric | PLA, PGA, PLGA, polycaprolactone (PCL) and polyethylene glycol (PEG), chitosan, polysaccharide, gelatin, starch | High biocompatibility, nontoxic by-products within the body and good sustained-release profiles | 17, 131 | |
2. | Dendrimers | Polyamidoamine (PAA), Polypropylenimine, Polyaryl ether (PAE) | Capable of encapsulating hydrophilic as well as hydrophobic molecules; Capable to cross various cell membranes or biological barriers, including the BBB through endocytosis | 130, 132 | |
3. | Nanogels | Water soluble and Cross-linked polymers like PEG | Greater surface area, unique softness and better drug loading capacity | 133 | |
4. | Micelles | L,D-lactine polycaprolactone, PEG | Improved drug stability and bioavailability | 86, 134 | |
5. | Liposomes | Spherical vesicles comprising of aqueous core surrounded with single or multiple amphiphilic lipid bilayers | Capable of encapsulating hydrophilic as well as hydrophobic molecules; efficiently delivery of therapeutic molecules, including drugs, vaccines, enzymes, proteins, and nucleic acids, and imaging agents for diagnostics by transcytosis, endocytosis and BBB disruption | 131, 135 | |
6. | SLNP | Colloidal nanocarriers comprising of surfactant-stabilized triglycerides, monoglycerides, complex glyceride mixtures, or waxes, hard fats | Enhanced entrapment efficiency for hydrophobic drugs; possess the advantages of both liposomes and polymeric nanoparticles; high physical stability, bioavailability, biocompatibility, drug protection, strict control of release, ease of preparation, efficient tolerance, and biodegradability without generating toxic by-products | 136, 137 | |
Inorganic Nanocarriers | |||||
1. | Fullerenes | Carbon-based nanomaterial structure; an allotrope of carbon formed as C60 and C70 | Antioxidant nature; effective in crossing the BBB when hybridized with a biologically active moiety; prevent disruption and leakage of mitochondrial membrane | 132, 139, 142 | |
2. | Graphene | 2D single layer of strongly packed carbon atoms; Hydroxyl, epoxyl and carboxyl groups modify the graphene to provide graphene oxide | Antioxidant responses; Anti-inflammatory responses; high drug target specificity; high drug efficiency | 148, 150, 153 | |
3. | Carbon Nanotubes | Cylindrical shaped carbon-based nanostructures | Increased surface area; High penetration power; Promotes neuronal activity, network communication and synaptic formation | 154 | |
Biological Vectors as Nanocarriers | |||||
1. | Viral Vectors | Retrovirus vectors, adenovirus vectors, lentivirus vectors, herpes simplex virus type 1, and adeno-associated virus vectors | Delivers a normal copy of a defective gene and subsequently reduce the harmful functions, thus fighting disease pathology | 131, 158 | |
2. | Extracellular Vesicles | Heterogenous cell-derived membrane structures; Exosomes and micro-vesicles | Easily cross BBB by adsorptive/receptor-mediated transcytosis; efficient drug delivery | 161, 162 | |